acquired
Stage
About
Ipsogen develops molecular diagnostic assays for oncology, with a focus on detecting and monitoring hematological malignancies (such as leukemias) through genetic marker and minimal residual disease tests.
Explore Ipsogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.